MJardin Group (CSE:MJAR) issued an update to shareholders through a letter from Rishi Gautam, chairman and CEO of the company.
As quoted in the press release:
MJardin Group continues to grow, innovate and execute on our operational plan as the first North American operator of scale in the legal cannabis sector. As important as the last four years have been to acquire and/or operate cultivation, extraction and retail facilities with our 450+ employee base, the next several years will be even more important and exciting as we leverage our operating engine and expand into additional cannabis markets.
For the global cannabis sector, we remain very early in its full evaluation. In 2018, we witnessed a volume of public offerings, large capital raises and some early signs of consolidation. In 2019, we expect to see even bigger transactions as the large players join forces to optimize their respective businesses, and a heightened level of innovation as our peers seek to differentiate themselves through various consumer-facing initiatives.
As the competitive landscape continues to evolve, one of our primary goals is to leverage our knowledge bank of operating experience to move at a swift, but methodical, pace to extend our current geographic and product footprint. Given the significant organic growth outlook in our Company’s existing portfolio base, we are not under any undue pressure to chase lower-tier transactions nor pay greater than fair value to enter certain markets.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).